Correlation Between Fonar and Myriad Genetics
Can any of the company-specific risk be diversified away by investing in both Fonar and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fonar and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fonar and Myriad Genetics, you can compare the effects of market volatilities on Fonar and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fonar with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fonar and Myriad Genetics.
Diversification Opportunities for Fonar and Myriad Genetics
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Fonar and Myriad is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Fonar and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Fonar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fonar are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Fonar i.e., Fonar and Myriad Genetics go up and down completely randomly.
Pair Corralation between Fonar and Myriad Genetics
Given the investment horizon of 90 days Fonar is expected to generate 0.7 times more return on investment than Myriad Genetics. However, Fonar is 1.44 times less risky than Myriad Genetics. It trades about -0.03 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.05 per unit of risk. If you would invest 2,010 in Fonar on November 3, 2024 and sell it today you would lose (435.00) from holding Fonar or give up 21.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fonar vs. Myriad Genetics
Performance |
| Timeline |
| Fonar |
| Myriad Genetics |
Fonar and Myriad Genetics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fonar and Myriad Genetics
The main advantage of trading using opposite Fonar and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fonar position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.| Fonar vs. Burning Rock Biotech | Fonar vs. Sera Prognostics | Fonar vs. Exagen Inc | Fonar vs. Castle Biosciences |
| Myriad Genetics vs. Guardant Health | Myriad Genetics vs. Caredx Inc | Myriad Genetics vs. Castle Biosciences | Myriad Genetics vs. Sotera Health Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |